Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  Smith & Nephew    SN.   GB0009223206

SMITH & NEPHEW (SN.)
My previous session
Most popular
  Report  
Delayed Quote. Delayed  - 08/17 05:35:11 pm
1379 GBp   +0.77%
08/09SMITH & NEPHEW : Additional Listing
PU
08/08NPWT DEVICES GL : The incidences of acute and chronic wounds caused ..
AQ
08/04SMITH & NEPHEW : A Field of 7
AQ
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets
The feature you requested does not exist. However, we suggest the following feature:

Smith & Nephew : Additional Listing

share with twitter share with LinkedIn share with facebook
share via e-mail
0
08/09/2018 | 12:40pm CEST

9 August 2018

SMITH & NEPHEW PLC

(the 'Company')

APPLICATION FOR BLOCK LISITING

Application has been made to The UK Listing Authority and The London Stock Exchange for a block listing of 952,000 ordinary shares ('Shares') of $0.20 each to trade on The London Stock Exchange and to be admitted to The Official List, with an expected admission date of 13 August 2018. The Shares shall rank equally with the existing issued Shares of the Company.

The block listing consists of ordinary shares to be issued under the following plans:

· 452,000 for the Smith & Nephew ShareSave Plan (2012)

· 500,000 for the Smith & Nephew International ShareSave Plan (2012)

Susan Swabey

Company Secretary

Smith & Nephew plc

Tel: 01923 477216

Disclaimer

Smith & Nephew plc published this content on 09 August 2018 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 09 August 2018 10:39:05 UTC

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on SMITH & NEPHEW
08/09SMITH & NEPHEW : Additional Listing
PU
08/08NPWT DEVICES GLOBAL MARKET TO 2025 & : The incidences of acute and chronic wound..
AQ
08/06SMITH & NEPHEW : Set of Locking Proximal Humeral Plate-5 Holes with Locking Scre..
AQ
08/04SMITH & NEPHEW : A Field of 7
AQ
07/27SMITH & NEPHEW : JOURNEY II BCS Knee System demonstrates improved patient outcom..
AQ
07/26Smith & Nephew buoyed by recovery in U.S. market
RE
07/26SMITH & NEPHEW : Half-year results
CO
07/20Today’s Free Research Reports Coverage on Neovasc and Three More Healthcare S..
AC
07/18ZIMMER BIOMET : Strategies For The $17 Billion Major Orthopedic Implants Market
AQ
07/10SMITH & NEPHEW : LCDCP Plate Hole of Smith & Nephew or Synthes or Zimmer
AQ
More news
News from SeekingAlpha
07/30Netflix re-releases documentary critical of medical device industry 
07/27Stryker's Exceptional Growth Supports A Gravity-Defying Valuation 
07/26Smith & Nephew Plc (SNN) CEO Namal Nawana on Q2 2018 Results - Earnings Call .. 
07/26Smith & Nephew plc 2018 Q2 - Results - Earnings Call Slides 
07/26Smith & Nephew plc reports 1H results 
Financials ($)
Sales 2018 4 976 M
EBIT 2018 1 008 M
Net income 2018 657 M
Debt 2018 1 084 M
Yield 2018 1,98%
P/E ratio 2018 22,60
P/E ratio 2019 19,40
EV / Sales 2018 3,30x
EV / Sales 2019 3,14x
Capitalization 15 333 M
Chart SMITH & NEPHEW
Duration : Period :
Smith & Nephew Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SMITH & NEPHEW
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 16
Average target price 18,7 $
Spread / Average Target 6,2%
EPS Revisions
Managers
NameTitle
Namal Nawana Chief Executive Officer & Executive Director
Roberto Quarta Chairman
Mark Gladwell President-Global Operations
Graham James Baker Chief Financial Officer & Director
Vasant Padmanabhan President-Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
SMITH & NEPHEW7.07%15 333
STRYKER CORPORATION9.78%63 571
WRIGHT MEDICAL GROUP NV24.05%2 918
JAPAN LIFELINE CO., LTD.-13.40%1 675
GLAUKOS CORP56.61%1 416
CERUS CORPORATION103.85%922